BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24842350)

  • 1. Secondary pure erythroid leukaemia in relapsed acute lymphoblastic leukaemia: lineage switch or chemotherapy effect?
    Gupta SK; Kumar R; Chharchhodawala T; Kumar L
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24842350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lineage switch - conversion of acute lymphoblastic leukaemia to acute myeloid leukaemia in 4 years old girl].
    Szpecht D; Derwich K; Wachowiak J; Konatkowska B; Dworacki G
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1041-4. PubMed ID: 19531823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage switch at relapse of childhood acute leukemia: a report of four cases.
    Park M; Koh KN; Kim BE; Im HJ; Jang S; Park CJ; Chi HS; Seo JJ
    J Korean Med Sci; 2011 Jun; 26(6):829-31. PubMed ID: 21655072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
    Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
    Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute monoblastic leukemia that switched lineage at relapse to acute lymphoblastic leukemia: a case report.
    Inoue A; Kawakami C; Takitani K; Ikemoto T; Tamai H
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):e258-60. PubMed ID: 22217491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of lineage switch from acute lymphoblastic leukemia to acute myeloid leukemia.
    Chung HJ; Park CJ; Jang S; Chi HS; Seo EJ; Seo JJ
    Korean J Lab Med; 2007 Apr; 27(2):102-5. PubMed ID: 18094559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy.
    Rayes A; McMasters RL; O'Brien MM
    Pediatr Blood Cancer; 2016 Jun; 63(6):1113-5. PubMed ID: 26914337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage Switch Between B-Lymphoblastic Leukemia and Acute Myeloid Leukemia Intermediated by "Occult" Myelodysplastic Neoplasm: Two Cases of Adult Patients With Evidence of Genomic Instability and Clonal Selection by Chemotherapy.
    Wu B; Jug R; Luedke C; Su P; Rehder C; McCall C; Lagoo AS; Wang E
    Am J Clin Pathol; 2017 Aug; 148(2):136-147. PubMed ID: 28898985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
    Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular involvement in acute lymphoblastic leukaemia.
    Tan AK; Azman A; Hoe TS; Rohana T
    Med J Malaysia; 1994 Dec; 49(4):409-11. PubMed ID: 7674978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment.
    Demosthenous C; Lalayanni C; Iskas M; Douka V; Pastelli N; Anagnostopoulos A
    Curr Probl Cancer; 2019 Jun; 43(3):222-227. PubMed ID: 29895435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
    Mughal T; Morleda J; Goldman J
    Acta Haematol; 1993; 89(3):149-51. PubMed ID: 8362603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia following preleukemic syndromes in adults.
    Escudier SM; Albitar M; Robertson LE; Andreeff M; Pierce S; Kantarjian HM
    Leukemia; 1996 Mar; 10(3):473-7. PubMed ID: 8642864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
    DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
    Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-Haematologic Parameters And Assessment Of Post-Induction Status In Acute Lymphoblastic Leukaemia.
    Niaz H; Malik HS; Mahmood R; Mehmood A; Zaidi SA; Nisar U
    J Ayub Med Coll Abbottabad; 2022; 34(3):458-462. PubMed ID: 36377156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of neonatal leukaemia.
    van der Linden MH; Creemers S; Pieters R
    Semin Fetal Neonatal Med; 2012 Aug; 17(4):192-195. PubMed ID: 22510298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.
    Cortes J; Perl AE; Döhner H; Kantarjian H; Martinelli G; Kovacsovics T; Rousselot P; Steffen B; Dombret H; Estey E; Strickland S; Altman JK; Baldus CD; Burnett A; Krämer A; Russell N; Shah NP; Smith CC; Wang ES; Ifrah N; Gammon G; Trone D; Lazzaretto D; Levis M
    Lancet Oncol; 2018 Jul; 19(7):889-903. PubMed ID: 29859851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.